Epilepsy in Pregnancy
BMJ 335:769-774, Tomson,T. &Hiilesmaa,V., 2007
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
Assessing Bioequivalence of Generic Antiepilepsy Drugs
Ann Neurol 70:221-228,192, Krauss, G.L.,et al, 2011
Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009
Lamotrigine Kinetics Within the Menstrual Cycle, After Menopause, and with Oral Contraceptives
Neurol 73:1388-1393, Wegner,I.,et al, 2009
Chitosan May Decrease Serum Valproate and Increase Risk of Seizure Reappearance
BMJ 339:a2163, Striano,P.,et al, 2009
Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006
Oxcarbazepine Concentrations During Pregnancy: A Retrospective Study in Patients with Epilepsy
Neurol 67:1497-1499, Christensen,J.,et al, 2006
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005
Seizures Following Reduction in Phenytoin Level After Orally Administered Folic Acid
Neurol 64:1982, Steinweg,D.L.&Bentley,M.L., 2005
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004
Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Effect of Food on Absorption of Dilantin Kapseals and Mylan Extended Phenytoin Sodium Capsules
Neurol 57 582-589,571, Wilder,B.J.,et al, 2001
Effect of Food on the Bioavailability of 100-mg Dilantin Kapseals
Neurol 57:698-700,571, Cook,J.,et al, 2001
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996
Appropriateness of Antiepileptic Drug Level Monitoring
JAMA 274:1622-1626, Schoenenbergber,R.A.,et al, 1995
Status Epilepticus and Antiepileptic Medication Levels
Neurol 44:47-50, Barry,E.&Hauser,W.A., 1994
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Seizure Exacerbation and Status Epilepticus Related to Carbamazepine-10, 11-Epoxide
Ann Neurol 35:743-746, So,E.L.,et al, 1994
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993
Carbamazepine Toxicity Resulting from Generic Substitution
Neurol 43:2696-2697, 24351993., Gilman,J.T.,et al, 1993
Acute Toxic Reaction to Carbamazepine:Clinical Effects and Serum Concentrations
J Pediatr 121:295-299, Tibballs,J., 1992
Therapeutic Bioequivalency Study of Brand Name Versus Generic Carbamazepine
Neurol 42:1147-1153, Oles,K.S.,et al, 1992
Phenytoin
BMJ 305:1215-1218, Aronson,J.K.,et al, 1992
A Rational Guide to Routine Blood Monitoring in Patients Receiving Antiepileptic Drugs
Neurol 41:961-964, Pellock,J.M.&Willmore,L.J., 1991
A Rapid, Noninstrumented Whole Blood Carbamazepine Assay for Pediatric Patients
J Pediatr 116:307-310, Cochran,E.B.,et al, 1990
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
The Effects of Storage and Shaking on the Settling Properties of Phenytoin Suspension
Neurol 39:207-209, Sarkar,M.A.,et al, 1989
Variability of Serum Phenytoin Concentrations in Nursing Home Patients
Arch Int Med 149:890-892, Mooradian,A.D.,et al, 1989
Level Off
Neurol 1009-1010, Dodson,W.E., 1989
Decreased Phenytoin Levels in Patients Receiving Chemotherapy
Am J Med 87:505-510, Grossman,S.A., 1989
Effect of Food on the Serum Concentration Profile of Enteric-Coated Valproic Acid
Neurol 38:1319-1322, Fischer,J.H.,et al, 1988
Overuse of Monitoring of Blood Concentrations of Antiepileptic Drugs
BMJ 294:723-724, Chadwick,D.W., 1987
The Measurement of Anticonvulsant Agent Levels
Ann Int Med 100:854-858, Troupin,A.S., 1984
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Methsuximide for Refractory Complex Partial Seizures
Neurol 31:741-744, Wilder,B.J.,et al, 1981
Low Blood Levels of Phenobarbital Due to Poor Gastrointestinal Solubility of Phenobarbital Tablets
Ann Neurol 9:309-310, Alvarez,N.,et al, 1981